Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about analyst meet

09 Feb 2021 Evaluate
Aurobindo Pharma has informed that an analyst/ investor call on the Unaudited Financial Results of the Company for the third quarter and nine months period ended 31st December 2020 is scheduled on 11th February 2021 at 08:30 hrs.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..